Stellar Diamonds shares leap as court approves its acquisition by NWF
A look at some of the biggest risers and fallers in London on Wednesday
Company
Futura Medical PLC
LON:FUM
Futura Medical specialises in the development and global commercialisation of innovative sexual health products, including lead product Eroxon®. The company's core strength lies in its research, development and commercialisation of topically delivered gel formulations in sexual health products.
298 stories · page 3 of 3
Futura Medical announces ‘highly encouraging results’ for its erectile dysfunction gel
Futura Medical said the study supports its strong belief that higher dose forms of MED2002 should improve efficacy, particularly in more severe cases
FTSE 100 pares losses as US bond yields rise above 3%
Resource stocks suffer as US dollar makes headway on forex markets
Archive
Proactive news snapshot: Symphony Environmental, AfriTin Mining, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Zoltav shares jump as it discovers reservoir on Bortovoy licence may be larger than expected
A look at some of the biggest risers and fallers in London on Wednesday
Futura Medical says discussions with commercial partner over erectile dysfunction drug are at an advanced stage
MED2002 is a rapid onset gel designed for those men where the current pill-based treatments aren’t appropriate, or carry significant side-effects
Investments and investor services
FTSE 100 closes in red as Wall Street suffers, but miners show support
FTSE 100 closed down around six points at 7,132 but big cap miners were up
Morrisons is not the basket case it once was
Previews of results statements from supermarket chain, Morrisons; insurer behemoth, the Pru, and infrastructure contractor, Balfour Beatty
Archive
Proactive news snapshot: Hemogenyx, Futura Medical, Active Energy Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Minoan Group jumps as it signs exclusivity deal for sale of Travel & Leisure division
A look at some of the biggest risers and fallers in London on Tuesday
Futura Medical encouraged by interim data
The definitive results of the company's pharmacokinetic study will be used to guide phase III clinical assessments of lead product, MED2002
FTSE 100 closes firmly lower as traders get jumpy about US politics
FTSE 100 finished almost 76 points lower at 7,138, while the FTSE 250 lost over 254 points at 19,863.
Archive
Chancellor's Spring Statement unlikely to include big spending plans, says think-tank
The week ahead includes the UK's budget statement and earnings from Morrisons, Prudential, Cairn Energy, Cineworld, Savills, Wetherspoons, Balfour Beatty and Fevertree
Archive
Proactive news snapshot: Tlou Energy, Orosur Mining, Futura Medical ...
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Tlou Energy rallies on new reserves statement
A look at some of today's top risers and fallers in London
Futura Medical welcomes former Shield Therapeutics FD to the board
Derek Martin has left Futura Medical to pursue other business interests
Investments and investor services
FTSE 100 makes up some ground to close a tad lower as earnings disappoint
The minister responsible for Britain's exit from the EU, David Davis said the UK would lead a “global race to the top"
Archive
Proactive news snapshot: Symphony Environmental Technologies, Futura Medical, LEKOIL …
A glance at some of the day's highlights from the Proactive Investors newswire
Ocado heads higher on reports of new contract win and renewed takeover speculation
Some of the main news-driven risers and fallers in London on Thursday...
Respected industry journal publishes data from phase II trial of Futura Medical’s MED2002 ED gel
The Journal of Sexual Medicine is a bit late to the party given that the headline results were announced back in September 2016 but Futura said it nonetheless shows the growing “level of scientific interest” in the gel
Investments and investor services
FTSE 100 feeds off Wall Street rally to close near 7,700
If you happen to work for a FTSE 100 company, your boss has already earned more in the past two-and-a-half days then the average UK employee will this year
Archive
Proactive news snapshot: Tertiary Minerals, Challenger Acquisitions, Futura Medical …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Parallel Media and Physiomics lead small cap market gainers
Some of the biggest risers and fallers in London on Wednesday
Futura Medical kicks off dosing and safety study that will guide phase III trials
Data from 40 men will determine the doses used in the final-stage clinical assessment MED2002
Investments and investor services
FTSE 100 closes lower as pound firms amid Brexit bill breakthrough
London's blue-chip index closed the day lower but retailers and housebuilders did well, oh, and there was some Brexit news...
Archive
Proactive news snapshot: Telit Communications, Sunrise Resources, Acal …
A glance at some of the day's highlights from the Proactive Investors newswire
Koovs jumps on partnership deal with online clothing retailer N Brown
A look at some of the biggest risers and fallers today in London
Most doctors think Futura’s erectile dysfunction gel is an improvement on Viagra and Cialis
“We are delighted by the results of this new survey, which not only reinforce the potential of MED2002 identified in our two earlier surveys but provide some important additional insights”
FTSE 100 closes in negative territory despite resource stock gains
The UK blue chip index closed at 7,526, well below the session peak of 7,557.00 and close to the day’s low of 7,531.48
Archive
Proactive news snapshot: Iofina, InnovaDerma, Columbus Energy Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Wildwood owner Tasty plunges once again as losses deepen amid sector-wide “slowdown”
Some of the main news-driven risers and fallers at 3.30pm...
Futura hails “excellent progress” in first half as erectile dysfunction gel moves closer to Phase III trial
“Futura made excellent progress in the first half of 2017 with MED2002, our breakthrough erectile dysfunction gel, which is moving close to its phase III programme”
Archive
Proactive news snapshot – Futura Medical, Anglo Pacific, Highlands Natural Resources…
A glance at some of the day's highlights from the Proactive Investors newswire
Futura Medical says Church & Dwight intends to terminate CSD500 erectogenic condom licensing agreement
The agreement, signed in April 2013, covered manufacturing, marketing and distribution rights to CSD500 in North America and certain countries in Europe
Archive
Proactive end of day news round-up: Tyratech, Futura Medical, 88 Energy ...
A glance at some of the stories on te Proactive newswire today
Passing of break-even milestone by MySQUAR prompts unexpected reaction
The Myanmar-language social media, entertainment and payments platform operator is breaking even at the current run-rate
Futura Medical shares boosted by step-up in investor roadshows
The presentation gives a a detailed insight into key aspects of the clinical development and commercial potential of the product.
Archive
Proactive news round-up: Sound Energy, Gemfields, Sunrise Resources...
A glance at some of the stories on the Proactive Investors newswire today
Sunrise Resources radiating positivity over pozzolan
Risers and fallers: Advanced Oncotherapy, St Ives, Intelligent Energy
Futura Medical chairman says there is “significant commercial interest” in its erectile dysfunction drug
Last month the company received a boost in the form of “constructive feedback” from regulators in both the UK and US reviewing the clinical trial requirements for MED2002.
Archive
Proactive news round-up: Eurasia Mining, Gemfields, OPG Power Ventures...
Some of the small cap stories on the Proactive newswire today
Styles&Wood Group heads higher on chipper outlook
Some of the main risers and fallers in London at 3.40pm
Futura Medical shares up as firm "delighted" by regulator feedback on erectile dysfunction drug
Written responses from America’s Food & Drug Administration and the Medicines & Healthcare products Regulatory Agency (MHRA) here in Britain support its timeline, which sees marketing approval for the product in the second-quarter of 2019.
FTSE 100 closes lower as election worries dent sentiment
The FTSE 100 closed down 6.56, or 0.09% to 7,519...
Illika accelerates away on US battery patent
Main share price risers and fallers in London at 3.45pm: Ilika, Halma, Public Service Props
Futura Medical encouraged by high level of interest from potential licensing partners for its erectile dysfunction gel
The £12mln fund-raise in November left the company tooled-up to develop its breakthrough erectile dysfunction
FTSE 100 closes higher with retailer Next top riser
FTSE 100 was three points higher at 7,238, Next rises strongly.
Archive
Next to report first annual profit decline in eight years as Brexit hurts retailers
Next plc is facing the industry-wide pressure of rising inflation but its issues are also company-specific
Frontera Resources surges after investor conference
Some of the largest rises and fallers at 3pm: Frontera, Franchise Brands, Starcom
Futura Medical inks Portugal distribution deal for its condom line
The company is partnering with F Lima, which supplies consumer brands to supermarkets and pharmacies.
Archive
Next firmly on the back foot as shoppers batten down hatches
Week ahead: Next, Kingfisher, Smiths Group ,Satellite Solutions ...
Urals Energy jumps on plans for Russian assets
Some of the largest rises and falls in London at 15:45pm: Urals Energy, Acacia Mining, Vela Technologies
Futura Medical has US$1bn plus product in MED2002 says new research
Ipsos predicts peak OTC or without prescription annual sales for MED2002 in excess of US$650mln
FTSE 100 stocks dragged lower by miners and copper price drop shock
The FTSE 100 was down 32 points to 7,342 shortly after 3.15pm on Monday
Archive
Proactive news round-up: H&T Group, Akers Biosciences, LGO Energy ...
A glance at some of the stories on the Proactive newswire today.
Futura Medical inks pain relief deal
The deal is with German group STADA, which owns Huddersfield-based Thornton & Ross.
Archive
Proactive news round-up: Futura Medical , Gfinity, Sound Energy ...
A glance at some of the stories on the Proactive newswire today
Futura's erectogenic condom launched in Saudi Arabia
The condoms will be marketed under the brand name Futura Max Manex Super.
Futura Medical: Octopus Investments lifts stake
Octopus now holds around 9.6 mln voting rights or 8.01% following the transaction.
Immupharma among the small cap pharmas in focus on Wednesday
Immupharma among the small cap pharmas in focus on Wednesday, alongside Futura Medical, Horizon Discovery Group, and Summit Therapeutics.
Futura’s ED treatment ‘more effective than first thought’
The company’s erectile dysfunction treatment can take as little as 60 seconds to have an effect
Futura Medical unveils twin strategy for flagship drug alongside new head of R&D
Futura said it has recruited Ken James, currently a non-executive director, to oversee its research and development efforts.
Proactive news summary: Arian Silver Corp, Diamondcorp, eg Solutions, Futura Medical, Strategic Minerals, Stobart Group, Versarien
On the day Misys called off its planned flotation, Futura and Strategic Minerals found willing buyers for their shares.
Futura Medical unveils plans to raise £12mln
“The placing is expected to allow the group to continue to fund additional product and commercial development activities and to seek additional licence agreements on more favourable terms than would otherwise be available,” the company said
Ready to go again? Futura Medical tipped to rally
The dust has settled after August's 300% rally, but technical analysis suggests the price will move higher again.
Futura Medical price has doubled, but is this just the beginning?
There is an argument, based on the company’s own research, that the current share price barely scratches the surface.
Futura Medical says shelf-life issue with condoms have been resolved
The CSD500 condom is close to regulatory approval for a longer shelf life and partner launch.
Risers and fallers: Sportech, JD Sports and Corero Network Security
Sportech is selling off The Football Pools to a group of gambling industry investors for nearly £100mln
Archive
UK stocks end higher as tech sector lights up with merger deal, oil prices rise
London shares closed higher on Thursday led by Britain’s biggest tech deal of the year and an advance by oil prices
Futura shares double after successful clinical trial
It means Futura now has a differentiated product in a market worth US$5bn that , currently dominated by top-selling drugs, such as Viagra and Cialis, that have limitations.
Risers and fallers, including Futura Medical and Windar Photonics
A look at some of today’s significant movers in London
Futura Medical trial success provides key to US$5bn drugs market
The study of 232 men successfully demonstrated MED2002’s efficacy, safety and speed of onset.
UK shares end higher as higher oil puts downbeat mixed output data in the shade
London shares closed firmer on Wednesday as mixed-to-downbeat manufacturing data was counterweighed by upbeat oil prices
Archive
SafeCharge in safe hands
Futura Medical on the rise
There has been a change in sentiment towards the pain relief and sexual health products specialist, as news flow has turned positive
Trending: Bremain Rovers drawn against Brexiter City in European tie
David Beckham wants in; Sol Campbell wants out (for a change). There's only one way to settle this, and that's a celebrity EU refendum footie match.
Risers & Fallers: Boxhill, EKF, GW Pharma, PV Crystalox, Smart Metering, SyQic
payment processing firm had some long overdue good news, saying first quarter sales were strong and in line with expectations.
Futura Medical sees clear potential for value generation
"We are very pleased with recent progress in the commercialisation of our product pipeline," chairman John Clarke said
Proactive daily news highlights: Featuring Lekoil, Sound Energy, Armadale Capital and more…
Lekoil nears commercial production in Nigeria; Sound Energy ready to start drilling second well; and Armadale records high graphite grades
Risers & Fallers: Ascent Resources, Hummingbird, Mkango ...
The European oil and gas exploration and production company Ascent lived up to its name as resolutions 1 to 3 were duly passed at today’s AGM.
Futura Medical unveils second condom distribution deal in a week
Futura said this Milsing tie-up is in line with strategy of licensing CSD500 to regional distributors in order to build a global distribution network. No financial details were given.
Risers & Fallers: Ascent Resources, Onzima Ventures, Aveva Group, ReNeuron Group, Egdon Resources, Plutus Powergen
The merger between Aveva Group and Schneider could be back on
Futura signs deals with Indian maker of SKORE condoms
TTK Protective Devices, part of the conglomerate TTK Group, will produce the Futura CSD500 prophylactic, which helps men maintain an erection, for distribution worldwide.
FTSE 100 closes lower as Fed rate rise fears weigh
The blue chip benchmark closed 1.82% down to 6,053, while the FTSE AIM100 lost 0.17% to 3,357
Futura looks to future as recruitment phase closes for pivotal trial
Already 110 have completed the four-month course of treatment with the other 82 expected to be through the process by the summer.
Investments and investor services
Risers & Fallers: Obtala, Plexus, Mirada, TomCo Energy, RedT Energy, Futura Medical
Valentin Bovykin has upped his stake in Obtala above 7%.
Futura Medical woos customers with longer-life condom
Pain relief and sexual health group makes progress with flagship products
Futura Medical Plc progresses condom and pain relief products
Health group expects to have more of a commercial focus in 2016
Tuesday's agenda: Kalibrate Technologies PLC's timing is good
There is a good chance Kalibrate's petrol station forecourt software will be put through its paces on Wednesday evening after the chancellor of the exchequer's budget speech.
Week Ahead: Brexit dilemma for Osborne
Chancellor of the Exchequer George Osborne gives his budget speech on Wednesday
Futura Medical has a lot to offer, says CEO
Futura has been making significant headway with MED2002 and may be in a position to bring in an industry partner next year.
Investments and investor services
Risers & Fallers: Drax, Renew Holdings, Solid State, Filtronic, Metal Tiger and Premier African
Below are the main news-driven share price movements at 4pm.
Wednesday's agenda - UK housing market again in focus with Barratt numbers
House builders are in focus again - with Barratt Developments....
Archive
Proactive news summary, including Tertiary Minerals, Medusa Mining and Ormonde Mining
A mixed bag but mining was prominent. Shares in flourspar explorer Tertiary Minerals rose after i upgraded the resource at its MB project in Nevada, USA, by more than double.
Futura Medical reports encouraging condom test results
Sexual health firm hopes to seek approval for its extended life condom later this year